Evidence map›Paper›PMID 31052590›Full record

ArticleMolecules (Basel, Switzerland)2019

Aspalathin-Rich Green Rooibos Extract Lowers LDL-Cholesterol and Oxidative Status in High-Fat Diet-Induced Diabetic Vervet Monkeys.

Patrick Orlando, Nireshni Chellan, Johan Louw, Luca Tiano, Ilenia Cirilli, Phiwayinkosi Dludla, Elizabeth Joubert, Christo J F Muller

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Coenzyme QInternational journal of molecular sciences · 2020
    Pooled it
  2. Article
  3. Article
  4. The effect ofFrontiers in physiology · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Patrick OrlandoDepartment of Life and Environmental Sciences, DiSVA-Biochemistry, Polytechnic University of Marche, 60131 Ancona, Italy. p.orlando@univpm.it.
Nireshni ChellanBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa. nireshni.chellan@mrc.ac.za.
Johan LouwBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa. johan.louw@mrc.ac.za.
Luca TianoDepartment of Life and Environmental Sciences, DiSVA-Biochemistry, Polytechnic University of Marche, 60131 Ancona, Italy. l.tiano@univpm.it.
Ilenia CirilliDepartment of Clinical Dental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy. pdludla@mrc.ac.za.
Phiwayinkosi DludlaBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa. christo.muller@mrc.ac.za.
Elizabeth JoubertPlant Bioactives Group, Post-Harvest and Agro-Processing Technologies, Agricultural Research Council (ARC), Infruitec-Nietvoorbij, Private Bag X5026, Stellenbosch 7599, South Africa. i.cirilli@pm.univpm.it.
Christo J F MullerBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council, Tygerberg 7505, South Africa. joubertL@arc.agric.za.
South African Medical Research Council · ZAMarche Polytechnic University · ITStellenbosch University · ZA

Funding

South African Medical Research Council 92724
6 · The paper itself

Abstract

Type 2 diabetic patients possess a two to four fold-increased risk for Cardiovascular Diseases (CVD). Hyperglycemia, oxidative stress associated with endothelial dysfunction and dyslipidemia are regarded as pro-atherogenic mechanisms of CVD. In this study, high-fat diet-induced diabetic and non-diabetic vervet monkeys were treated with 90 mg/kg of aspalathin-rich green rooibos extract (Afriplex GRT) for 28 days, followed by a 1-month wash-out period. Supplementation showed improvements in both the intravenous glucose tolerance test (IVGTT) glycemic area under curve (AUC) and total cholesterol (due to a decrease of the low-density lipoprotein [LDL]) values in diabetics, while non-diabetic monkeys benefited from an increase in high-density lipoprotein (HDL) levels. No variation of plasma coenzyme Q10 (CoQ

Indexed as

AnimalsBiomarkersBlood GlucoseChalconesChlorocebus aethiopsCholesterol, LDLDiabetes Mellitus, ExperimentalDiet, High-FatDisease Models, AnimalFemaleHypoglycemic AgentsLipidsLipoproteins, LDLMaleOxidation-ReductionOxidative StressaspalathinBiomarkersBlood GlucoseChalconesCholesterol, LDLcoenzyme Q10Hypoglycemic AgentsLipidsLipoproteins, LDLoxidized low density lipoproteinPlant ExtractsUbiquinoneantidiabetic activityaspalathin-enriched green rooibos extractcardiovascular risk factorscoenzyme Q10type 2 diabetes

Identifiers

PMID31052590
PMCPMC6539440
OpenAlexW2943165878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.